Mexico Republic specific Pollen Allergies Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	128 Pages	Data Bridge Market Research	September, 2022	DAABD17403941

Best Price Guarantee
Price	from $3,500
Length	128 Pages
Publisher	Data Bridge Market Research
Published Date	September, 2022
SKU	DAABD17403941

Mexico Republic specific Pollen Allergies Market

The Mexico specific pollen allergies market is projected to register a substantial CAGR of 6.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation
Mexico Specific Pollen Allergies Market, By Drug Type (Antihistamines, Decongestants, Corticosteroids, Anticholinergics and Others), Diagnostic Test (In Vivo Test and In Vitro Test), Product (Instruments, Reagents and Kits, and others), End User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Mexico) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Mexico specific pollen allergies market are:

• Increasing prevalence of allergic disorder
• Wide range of product portfolio offered by major players

Market Players

The key market players for the Mexico specific pollen allergies market are listed below:

• Siemens Healthcare GmbH
• Sanofi
• bioMérieux SA
• GSK plc.
• Minaris Medical America, Inc.
• Quest Diagnostics Incorporated
• Circassia
• Alcon Inc.
• Thermo Fisher Scientific Inc
• Johnson & Johnson SA de CV
• Lincoln Diagnostics, Inc
• EUROIMMUN Medizinische Labordiagnostika AG
• Bayer Pharmaceuticals,
• Prestige Consumer Healthcare Inc.
• CINFA LABORATORIES
• Perrigo Company plc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Mexico Specific Pollen Allergies Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Product Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces Model; 4.3 Current Patents That Can Be Used In Allopathic Medicines In Mexico-; 4.4 Invention Patent-; 4.5 Country Level Analysis
5 Regulations: 5.1 Mexico
6 Market Overview: 6.1 Drivers; 6.1.1 Increase In Prevalence Of Allergic Disorder; 6.1.2 Wide Range Of Product Portfolios Offered By Major Player; 6.1.3 Impact Of Pollen Allergies On Paediatrics Population; 6.1.4 Health Sector Reform And Expansion Of Programmes To Boost Healthcare Spending; 6.2 Restraints; 6.2.1 Side Effects Associated With The Use Of Drugs; 6.2.2 Increase In Trend Of Using Home Remedies/Phytochemicals; 6.3 Opportunities; 6.3.1 Increase In The Environmental Pollution; 6.3.2 Awareness Of The Use Of Otc Products; 6.3.3 Relaxation Of Rules On Direct-to-consumer Advertising; 6.4 Challenges; 6.4.1 Increase In Abuse Potential; 6.4.2 Intellectual Property Rights Law
7 Mexico Specific Pollen Allergies Market, By Drug Type: 7.1 Overview; 7.2 Antihistamine; 7.2.1 Antihistamine, By Drug Type; 7.2.2 Levocetirizine; 7.2.3 Cetirizine; 7.2.4 Loratidine; 7.2.5 Diphenhydramine; 7.2.6 Chlorpheniramine; 7.2.7 Fexofenadine; 7.3 Corticosteroids; 7.3.1 Fluticasone Propionate; 7.3.2 Triamcinolone/Triamcinolone Acetonoid; 7.3.3 Cromolyn Sodium; 7.3.4 Others; 7.4 Decongestants; 7.4.1 Decongestants, By Drug Type; 7.4.2 Pseudoephedrine; 7.4.3 Phenylephrine; 7.4.4 Oxymetazoline; 7.4.5 Others; 7.5 Anticholinergics; 7.5.1 Anticholinergics, By Drug Type; 7.5.2 Ipratropium Bromide; 7.5.3 Others; 7.6 Others
8 Mexico Specific Pollen Allergies Market, By Products: 8.1 Overview; 8.2 Instruments; 8.2.1 Immuno Assay Analyzer; 8.2.2 Products, By Immunoassay Analyzer; 8.3 Radio Immuno Assay (Ria); 8.4 Counting Immuno Assay (Cia); 8.5 Enzyme Linked Immuno-sorbent Assays (Elisa); 8.6 Fluoroimmnoassay (Fia); 8.7 Chemiluminescence Assay; 8.7.1 Luminometers; 8.8 Reagents And Kits; 8.9 Others
9 Mexico Specific Pollen Allergies Market, By Diagnostic Test: 9.1 Overview; 9.2 In Vivo Test; 9.2.1 In Vivo Test, By Diagnostic Test; 9.2.2 Skin Prick; 9.2.2.1 Skin Prick, By Diagnostic Test; 9.2.2.2 Greer Prick; 9.2.3 The Stellar Point; 9.2.4 Phazet; 9.2.5 Bifurcated Smallpox Vaccination Test; 9.2.6 23g Intravenous Needle; 9.2.7 Others; 9.2.8 Patch Test; 9.2.9 Intradermal Test; 9.3 In Vitro Test; 9.3.1 In Vitro Test, By Diagnostic Test; 9.3.2 Serum Specific Ige Assay; 9.3.3 Total Ige Assay; 9.3.4 Basophil Activation Test
10 Mexico Specific Pollen Allergies Market, By End User: 10.1 Overview; 10.2 Hospitals; 10.3 Diagnostics Laboratories; 10.4 Academic And Research Institutes; 10.5 Others
11 Mexico Specific Pollen Allergies Market, By Distribution Channel: 11.1 Overview; 11.2 Direct Tender; 11.3 Retail Sales; 11.3.1 Retail Sales, By Type; 11.3.2 Hospital Pharmacy; 11.3.3 Retail Pharmacy; 11.3.4 Online Pharmacy
12 Mexico Specific Pollen Allergies Market: Company Landscape: 12.1 Company Share Analysis: Mexico Specific Pollen Allergies Market
13 Swot Analysis
14 Company Profile: 14.1 Glaxosmithkline Plc; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Product Portfolio; 14.1.4 Recent Developments; 14.2 Johnson & Johnson Services, Inc; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Product Portfolio; 14.2.4 Recent Developments; 14.3 Perrigo Company Plc; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Product Portfolio; 14.3.4 Recent Developments; 14.4 Siemens Healthcare Gmbh; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Product Portfolio; 14.4.4 Recent Developments; 14.5 Thermo Fisher Scientific Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Product Portfolio; 14.5.4 Recent Development; 14.6 Bayer Ag; 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Alcon Inc.; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Developments; 14.8 Biomérieux, Sa.; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Developments; 14.9 Cinfa Laboratories; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Development; 14.10 Circassia; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Euroimmun Medizinische Labordiagnostika Ag; 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Developments; 14.12 Lincoln Diagnostics, Inc.; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Developments; 14.13 Minaris Medical America, Inc.; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Developments; 14.14 Prestige Consumer Healthcare Inc.; 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Development; 14.15 Quest Diagnostics Incorporated; 14.15.1 Company Snapshot; 14.15.2 Revenue Analysis; 14.15.3 Product Portfolio; 14.15.4 Recent Development; 14.16 Sanofi; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis; 14.16.3 Product Portfolio; 14.16.4 Recent Developments
15 Questionnaire
16 Related Reports 128
List Of Tables: Table 1 Levocetirizine / Montelukast- Glenmark Pharmaceuticals Limited; Table 2 Levocetirizine And Montelukast-; Table 3 Drugs In Mexico Should Be Registered (Sanitary Registry/Health Record) With Cofepris Before Marketing In Mexico.; Table 4 Mexico Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Usd Million); Table 5 Mexico Antihistamine Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Usd Million); Table 6 Mexico Antihistamine Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Units); Table 7 Mexico Corticosteroids Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Usd Million); Table 8 Mexico Corticosteroid Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Units); Table 9 Mexico Decongestants Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Usd Million); Table 10 Mexico Decongestants Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Units); Table 11 Mexico Anticholinergic Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Usd Million); Table 12 Mexico Anticholinergics Drug Type In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Units); Table 13 Mexico Specific Pollen Allergies Market, By Products, 2020-2029 (Usd Million); Table 14 Mexico Instruments In Specific Pollen Allergies Market, By Products, 2020-2029 (Usd Million); Table 15 Mexico Immuno Assay Analyzer In Specific Pollen Allergies Market, By Products, 2020-2029 (Usd Million); Table 16 Mexico Specific Pollen Allergies Market, By Diagnostic Test, 2020-2029 (Usd Million); Table 17 Mexico In Vivo Test In Specific Pollen Allergies Market, By Diagnostic Test, 2020-2029 (Usd Million); Table 18 Mexico Skin Prick Test In Specific Pollen Allergies Market, By Drug Type, 2020-2029 (Usd Million); Table 19 Mexico In Vitro Test In Specific Pollen Allergies Market, By Diagnostic Test, 2020-2029 (Usd Million); Table 20 Mexico Specific Pollen Allergies Market, By End User, 2020-2029 (Usd Million); Table 21 Mexico Specific Pollen Allergies Market, By Distribution Channel, 2020-2029 (Usd Million); Table 22 Mexico Retail Sales In Specific Pollen Allergies Market, By Type, 2020-2029 (Usd Million) 89
List Of Figures: Figure 1 Mexico Specific Pollen Allergies Market: Segmentation; Figure 2 Mexico Specific Pollen Allergies Market: Data Triangulation; Figure 3 Mexico Specific Pollen Allergies Market: Droc Analysis; Figure 4 Mexico Specific Pollen Allergies Market : Country Vs Regional Market Analysis; Figure 5 Mexico Specific Pollen Allergies Market : Company Research Analysis; Figure 6 Mexico Specific Pollen Allergies Market: Interview Demographics; Figure 7 Mexico Specific Pollen Allergies Market: Dbmr Market Position Grid; Figure 8 Mexico Specific Pollen Allergies Market: Market End User Coverage Grid; Figure 9 Mexico Specific Pollen Allergies Market: Vendor Share Analysis; Figure 10 Mexico Specific Pollen Allergies Market: Segmentation; Figure 11 The High Prevalence Of Allergic Response And Increasing Approval Of New Product Is Expected To Drive The Mexico Specific Pollen Allergies Market In The Forecast Period Of 2022 To 2029; Figure 12 Drug Type Segment Is Expected To Account For The Largest Share Of The Mexico Specific Pollen Allergies Market In 2022 & 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of Mexico Specific Pollen Allergies Market; Figure 14 Mexico Specific Pollen Allergies Market, By Drug Type, 2021; Figure 15 Mexico Specific Pollen Allergies Market, By Products, 2021; Figure 16 Mexico Specific Pollen Allergies Market, By Diagnostic Test, 2021; Figure 17 Mexico Specific Pollen Allergies Market, By End User, 2021; Figure 18 Mexico Specific Pollen Allergies Market, By Distribution Channel, 2021; Figure 19 Mexico Specific Pollen Allergies Market: Company Share 2021 (%) 90